4 November 2025
Baker McKenzie advises on Keensight Capital’s acquisition of a majority stake in Bedfont Scientific Ltd.
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nick O'Grady Lead | Baker McKenzie | Partner | Banking & Finance | Not stated |
| Lana Ahern | Baker McKenzie | Senior associate | Not stated | Not stated |
| Natalie Lawman | Baker McKenzie | Associate | Not stated | Not stated |
| Sarah Hyland | Baker McKenzie | Associate | Not stated | Not stated |
| Ed Walters | Baker McKenzie | Trainee | Not stated | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Not stated
- Counterparties
- Keensight Capital (Buy-side)
Bedfont Scientific Ltd. (Target)